Browse by Aston Author

Up a level
Export as [feed] Atom [feed] RSS
Group by: Item Type | Date | No Grouping
Jump to: Article | Thesis
Number of items: 22.

Article

Lattmann, Eric, Russell, Steven T, Singh, Mankaran, Narayanan, Ramesh, Balaram, Padinjarethalakal N. and Lattmann, Pornthip (2018). N‒substituted 5‒hydroxy‒pyrrol‒2‒ones based cholecystokinin‒2 antagonists as experimental anticancer agents for the treatment of lung cancer. Drug Design, Development and Therapy, 2 (4), pp. 180-189.

Lattmann, E., Russell, S.T., Schwalbe, C.H., Shortt, A., Balaram, P.N., Theochari, E., Alharbi, M., Narayanan, R. and Lattmann, P. (2016). Cholecystokinin-1 receptor antagonists:5-hydroxy-5-aryl-pyrrol-2-ones as anticancer agents. MedChemComm, 7 (6), pp. 1138-1145.

Claudius, Ann-Katrin, Kankipati, Chandra S., Kilari, Rajagopal S., Hassan, Sadiya, Guest, Kerry, Russell, Steven T., Perry, Chris J., Stark, Lesley A. and Nicholl, Iain D. (2014). Identification of aspirin analogues that repress NF-κB signalling and demonstrate anti-proliferative activity towards colorectal cancer in vitro and in vivo. Oncology Reports, 32 (4), pp. 1670-1680.

Russell, Steven T. and Tisdale, Michael J. (2012). Role of β-adrenergic receptors in the oral activity of zinc-α2-glycoprotein (ZAG). Endocrinology, 153 (10), pp. 4696-4704.

Russell, Steven T. and Tisdale, Michael J. (2012). Role of β-adrenergic receptors in the anti-obesity and anti-diabetic effects of zinc-α2-glycoprotien (ZAG). BBA - Molecular and Cell Biology of Lipids, 1821 (4), pp. 590-599.

Russell, Steven and Tisdale, Michael (2011). Studies on the anti-obesity activity of zinc-α2-glycoprotein in the rat. International Journal of Obesity, 35 (5), pp. 658-665.

Russell, Steven and Tisdale, Michael (2011). Studies on the antiobesity effect of zinc-α2-glycoprotein in the ob/ob mouse. International Journal of Obesity, 35 (3), pp. 345-354.

Russell, Steven (2010). Adipokines have a role to play in the treatment of metabolic disease. Future Medicinal Chemistry, 2 (12), pp. 1721-1724.

Russell, Steven, Siren, Pontus M.A., Siren, Matus J. and Tisdale, Michael (2010). The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate. British Journal of Cancer, 102 (5), 833–836.

Russell, Steve T., Siren, P.M.A., Siren, M.J. and Tisdale, Michael J. (2009). Attenuation of skeletal muscle atrophy in cancer cachexia by d-myo-inositol 1,2,6-triphosphate. Cancer Chemotherapy and Pharmacology, 64 (3), pp. 517-527.

Russell, Steve T., Eley, Helen L., Wyke, Stacey M. and Tisdale, Michael J. (2008). Involvement of phosphoinositide 3-kinase and Akt in the induction of muscle protein degradation by proteolysis-inducing factor. Biochemical Journal, 409 (Part 3), pp. 751-759.

Eley, H., Russell, S.T. and Tisdale, M.J. (2007). Attenuation of muscle atrophy in a murine model of cachexia by inhibition of the dsRNA-dependent protein kinase. British Journal of Cancer, 96 (8), pp. 1216-1222.

Bing, C., Russell, S., Becket, E., Pope, M., Tisdale, M.J., Trayhurn, P. and Jenkins, J.R. (2006). Adipose atrophy in cancer cachexia:morphologic and molecular analysis of adipose tissue in tumour-bearing mice. British Journal of Cancer, 95 (8), pp. 1028-1037.

Khal, J., Wyke, S.M., Russell, Steve T., Hine, Anna V. and Tisdale, Michael J. (2005). Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia. British Journal of Cancer, 93 (7), pp. 774-780.

Sanders, P.M., Russell, S.T. and Tisdale, M.J. (2005). Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia. British Journal of Cancer, 93 (4), pp. 425-434.

Russell, Steve T. and Tisdale, Michael J. (2005). The role of glucocorticoids in the induction of zinc-α2-glycoprotein expression in adipose tissue in cancer cachexia. British Journal of Cancer, 92 (5), pp. 876-881.

Wyke, S.M., Russell, Steve T. and Tisdale, Michael J. (2004). Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-κB activation. British Journal of Cancer, 91 (9), pp. 1742-1750.

Wynter, Michael P., Russell, Steve T. and Tisdale, Michael J. (2004). Effect of n-3 fatty acids on the antitumour effects of cytotoxic drugs. In Vivo, 18 (5), pp. 543-548.

Russell, S.T. and Tisdale, M.J. (2002). Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo. British Journal of Cancer, 87 (5), pp. 580-584.

Bing, C., Russell, S.T., Beckett, E.E., Collins, P., Taylor, S., Barraclough, R., Tisdale, M.J. and Williams, G. (2002). Expression of uncoupling proteins-1,-2 and-3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor. British Journal of Cancer, 86 (4), pp. 612-618.

Russell, Steve T., Hirai, K. and Tisdale, Michael J. (2002). Role of β3-adrenergic receptors in the action of a tumour lipid mobilizing factor. British Journal of Cancer, 86 (3), pp. 424-428.

Thesis

Russell, Steven T. (2002). The mode of action of a lipid mobilising factor in cancer cachexia. PHD thesis, Aston University.

This list was generated on Sun Jul 21 01:45:00 2019 BST.